Table:
Discovery GWAS |
Follow-up |
Total | |||
---|---|---|---|---|---|
US | UK | UUS | CleanUP-IPF | ||
FVC | |||||
Sample size | 142 | 314 | 592 | 281 | 1329 |
Study centres | 3 | 4 | 6 | 1 | 14 |
Sex | |||||
Female | 34 (23∙9%) | 90 (28∙7%) | 143 (24∙2%) | 57 (20∙3%) | 324 (24∙4%) |
Male | 108 (76∙1%) | 224 (71∙3%) | 449 (75∙8%) | 224 (79∙7%) | 1005 (75∙6%) |
Mean age at baseline, years | 65∙7 (8∙3) | 71∙7 (8∙2) | 68∙8 (8∙0) | 71∙3 (7∙4) | 69∙7 (8∙2) |
Total number of visits | 604 | 1440 | 2516 | 656 | 5216 |
Mean number of visits per person | 4∙3 (1∙8) | 4∙6 (2∙1) | 4∙3 (1∙8) | 2∙3 (0∙5) | 3∙9 (1∙9) |
Maximum number of visits | 13 | 12 | 14 | 3 | 14 |
Number of deaths | 27 (19∙0%) | 110 (35∙0%) | 136 (23∙0%) | 11 (3∙9%) | 284 (21∙4%) |
DLCO | |||||
Sample size | 75 | 293 | 361 | 246 | 975 |
Study centres | 2 | 4 | 4 | 1 | 11 |
Sex | |||||
Female | 15 (20∙0%) | 79 (27∙0%) | 88 (24∙4%) | 54 (22∙0%) | 236 (24∙2%) |
Male | 60 (80∙0%) | 214 (73∙0%) | 273 (75∙6%) | 192 (78∙1%) | 739 (75∙8%) |
Mean age at baseline, years | 67∙5 (8∙5) | 71∙5 (8∙2) | 69∙2 (8∙1) | 71∙1 (7∙4) | 70∙2 (8∙1) |
Total number of visits | 251 | 1146 | 1398 | 566 | 3361 |
Mean number of visits per person | 3∙3 (1∙4) | 3∙9 (1∙7) | 3∙9 (1∙7) | 2∙3 (0∙5) | 3∙4 (1∙7) |
Maximum number of visits | 7 | 11 | 13 | 3 | 13 |
Number of deaths | 17 (22∙7%) | 94 (32∙1%) | 112 (31∙0%) | 9 (3∙7%) | 232 (23∙8%) |
Data are n, n (%), or mean (SD). CleanUP-IPF=Clinical Efficacy of Antimicrobial Therapy Strategy Using Pragmatic Design in Idiopathic Pulmonary Fibrosis study. DLCO=diffusing capacity of the lung for carbon monoxide. FVC=forced vital capacity. GWAS=genome-wide association study. USS=US, UK, and Spain.